Gonadotropin-releasing hormone antagonists do not influence the secretion of steroid hormones but affect the secretion of vascular endothelial growth factor from human granulosa luteinized cell cultures-Reference-Cited by-同舟云学术

Gonadotropin-releasing hormone antagonists do not influence the secretion of steroid hormones but affect the secretion of vascular endothelial growth factor from human granulosa luteinized cell cultures

Published:2006-09 Issue:3 Volume:86 Page:636-641
ISSN:0015-0282
Container-title:Fertility and Sterility
language:en
Short-container-title:Fertility and Sterility

Author:

Asimakopoulos Byron,Nikolettos Nikos,Nehls Barbara,Diedrich Klaus,Al-Hasani Safaa,Metzen Eric

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Reproductive Medicine

Reference35 articles.

1. Vascular endothelial growth factor is essential for corpus luteum angiogenesis;Ferrara;Nat Med,1998

2. Role of vascular endothelial growth factor in ovarian physiology and pathology;Geva;Fertil Steril,2000

3. Vascular endothelial growth factor: basic science and clinical progress;Ferrara;Endocrine Rev,2004

4. Angiogenesis in developing follicle and corpus luteum;Tamanini;Reprod Dom Anim,2004

5. Secretion of vascular endothelial growth factor/vascular permeability factor from human luteinized granulosa cells is human chorionic gonadotrophin dependent;Neulen;Mol Hum Reprod,1998

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of cetrorelix in the prevention and treatment of ovarian hyperstimulation syndrome: A prospective case control study;The Journal of Community Health Management;2024-01-15

2. The HERA (Hyper-response Risk Assessment) Delphi consensus for the management of hyper-responders in in vitro fertilization;Journal of Assisted Reproduction and Genetics;2023-09-15

3. Gonadotropin releasing hormone (GnRH) antagonist administration to decrease the risk of ovarian hyperstimulation syndrome in GNRH agonist cycles triggered with human chorionic gonadotropin;Archives of Gynecology and Obstetrics;2022-08-06

4. Ovarian Hyperstimulation Syndrome after GnRH Agonist Triggering and Freeze-All Protocol? Never Not, Hardly Ever: A Systematic Review of Case Reports;Gynecologic and Obstetric Investigation;2022

5. Impact of an oral gonadotropin‐releasing hormone antagonist on severe ovarian hyperstimulation syndrome in a patient with breast cancer who received a sustained‐release gonadotropin‐releasing hormone agonist: A case report;Journal of Obstetrics and Gynaecology Research;2021-10-12